Evaluation of heart failure management in a Military Hospital

Arch Cardiovasc Dis. 2008 Apr;101(4):235-41. doi: 10.1016/s1875-2136(08)73698-2.

Abstract

Purpose: Evaluate heart failure management in a Military Hospital in 2005.

Methods: Retrospective audit of 46 case records of patients hospitalised with heart failure within the framework of an accreditation procedure.

Results: The left ventricular ejection fraction was evaluated in 85% of cases during the reference hospital stay. Systolic heart failure was detected in 63% of cases. At least one NT-proBNP assay was performed for each patient. A global assessment was systematically performed, except for the mini mental state examination in patients aged over 75 years who represented 80% of patients. Initial therapeutic education was provided for 50% of systolic heart failure patients. Prescription rates in systolic heart failure were 76% for angiotensin-converting enzyme inhibitors, 7% for angiotensin receptor antagonists; 84% for at least one medicinal product in the above 2 classes; 68% for beta-blockers and 32% for spironolactone. A hospital discharge report was available for 93% of the patients. Elective re-admissions to hospital for uptitration of treatment concerned 10% of systolic heart failure patients. Emergency hospital re-admissions after a cardiovascular event (usually decompensation), concerned 35% of patients, after an average duration of one year of follow-up. These latter re-admissions, often repeated, led to 4% of additional hospital deaths. The initial hospital mortality rate was 13%.

Conclusion: Therapeutic patient education is under development. Medication may still be optimised, both qualitatively and quantitatively. Surveillance is planned with a yearly audit.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Diet
  • Diuretics / therapeutic use
  • Drug Utilization
  • Follow-Up Studies
  • France / epidemiology
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Heart Failure / etiology
  • Hospital Mortality
  • Hospitalization
  • Hospitals, Military
  • Humans
  • Life Style
  • Medical Audit*
  • Natriuretic Peptide, Brain / blood
  • Patient Education as Topic
  • Patient Readmission / statistics & numerical data
  • Peptide Fragments / blood
  • Quality Assurance, Health Care
  • Retrospective Studies
  • Spironolactone / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin II Type 1 Receptor Blockers
  • Diuretics
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
  • Spironolactone